News

Uber beat Q2 profit expectations and reported strong growth in rides and food deliveries, suggesting resilient consumer spending despite economic headwinds. However, the share price decline despite earnings growth suggests investors are either pricing in higher expectations or concerned about forward guidance—watch for commentary on margin pressures and competitive intensity. For Australian investors, Uber's performance is a bellwether for consumer discretionary spending and gig economy health in developed markets.

Eli Lilly reported a 48% revenue increase driven by stronger-than-expected demand for its GLP-1 drugs Mounjaro and Zepbound, signalling continued market growth in the obesity and diabetes treatment space. This result underscores the blockbuster potential of GLP-1 therapeutics and validates the sector's expansion beyond initial forecasts, though it also highlights intense competition as other pharma players like Novo Nordisk scale similar offerings. For Australian investors, this strengthens the outlook for healthcare and pharmaceutical stocks, particularly those with exposure to metabolic disease treatments, and may influence how the ASX's healthcare sector performs relative to broader markets.

Eli Lilly delivered a strong earnings beat with $23B in revenue, driven by surging demand for its GLP-1 drugs Mounjaro (diabetes) and Zepbound (weight loss), which collectively saw volume grow 60% year-on-year. This result reflects the ongoing blockbuster momentum in the obesity and diabetes treatment class, where Lilly competes with Novo Nordisk—a competitive dynamic that's reshaping pharma valuations globally. For Australian investors, this signals sustained strength in the obesity-drug sector and validates the broader healthcare opportunity, though it also highlights Lilly's execution risk if demand eventually normalises.

CVS Health beat Q2 earnings expectations and raised its full-year 2026 guidance, signalling operational resilience in the US healthcare and pharmacy sector. This is positive for the broader healthcare space, though CVS is primarily US-listed and has limited direct ASX exposure. Australian investors with exposure to US healthcare or pharmacy benefit managers via ETFs or direct holdings should note the positive momentum, though the real earnings power and margin sustainability will depend on detailed commentary around PBM margins, which have faced regulatory scrutiny.

The FAO's warning of rising food prices signals persistent inflationary pressure globally, which could complicate central banks' efforts to control inflation and may delay rate cuts. For Australian investors, this matters because rising food costs feed into CPI data that influences RBA policy, and it supports commodity prices—particularly for agricultural exports where Australia is a major producer. Watch for upcoming CPI prints and any RBA commentary on food-driven inflation.

The government is shifting public procurement rules to prioritise job creation, particularly targeting youth unemployment. This could boost labour-intensive sectors like construction and infrastructure by increasing demand for workers on government-funded projects, though it may add complexity and cost to tendering processes. Australian investors should watch how this affects contractor margins and whether it translates into sustained employment gains or simply reshuffles existing work—the policy's real impact depends on whether it genuinely creates new public spending or redirects existing contracts.

The Trump administration has refunded $100bn (60%) of $165bn in tariffs ruled illegal by the US Supreme Court, with the process still ongoing. This reduces near-term corporate cash drains but leaves $65bn outstanding, creating uncertainty about timing and potential disputes over remaining refunds. For Australian exporters and companies with US supply chains, the gradual refund process signals continued tariff volatility—watch for further court decisions and whether the administration accelerates remaining payouts or contests specific claims.

BlackRock and JPMorgan are expanding tokenized asset offerings in Europe, allowing investors to hold money market fund shares on blockchain across major currencies (GBP, EUR, USD). This represents institutional-grade adoption of blockchain finance and signals growing confidence in digital assets among tier-1 financial firms. For Australian investors, this highlights the acceleration of tokenization trends that could reshape how funds are traded globally, though direct local impact remains modest unless Australian regulators move to enable similar offerings on domestic platforms.

Australia's drought conditions are threatening vegetable yields, with farmers warning of a potentially record-poor harvest. This will likely flow through to higher grocery prices and reduced availability on supermarket shelves, adding to cost-of-living pressures for consumers—particularly relevant as the RBA watches inflation trends. Watch for broader food price inflation in CPI data and potential impacts on retailer margins if they absorb vs. pass on costs.

Global equities rallied on renewed AI enthusiasm, offsetting mixed signals from individual tech names like SpaceX and AMD. The UK services sector's return to growth in July—driven by consumer spending and technology demand—signals a potential economic rebound in a major developed economy, which could ease central bank rate-cut hesitancy. Oil holding at ~$80/bbl on Middle East ceasefire hopes adds stability to energy prices; Australian investors should monitor whether this reflects genuine geopolitical de-escalation or a temporary respite.

The federal government is moving to enforce renewable energy requirements on new AI datacentres through legislation that will override state objections from Queensland and NT. This matters because datacentres are massive energy consumers—forcing them onto renewables could accelerate Australia's grid transition but may increase operational costs for tech companies and strain regional power networks. For Australian investors, watch how this affects energy infrastructure stocks, renewable capacity providers, and whether it influences AI/tech sector investment decisions in Australia versus overseas.

The Eurozone composite PMI rising to 52.0 in July—its highest in 8 months—signals improving economic momentum across the region's manufacturing and services sectors. This data strengthens the case for the ECB to hold interest rates steady or potentially ease further as inflation moderates, which typically supports risk assets and weakens the euro. For Australian investors, a healthier European economy is modestly positive for ASX-listed exporters and multinationals with eurozone exposure, though the direct impact is secondary compared to US or China economic data.

Endeavour Group, Australia's second-largest retailer, has written down $311m in assets and reported a significant profit decline, signalling operational stress across its Dan Murphy's and BWS liquor brands and broader retail division. The asset write-down typically reflects management's reassessment of store or asset values amid weaker trading conditions—a red flag for retail fundamentals. For ASX investors, this highlights consumer spending weakness in discretionary categories and raises questions about earnings sustainability, though the 'business reset' commentary suggests management is taking action; watch FY24 guidance and same-store sales trends closely.

The US is accelerating domestic critical minerals production through increased funding and regulatory fast-tracking, creating demand tailwinds for ASX-listed miners and explorers with exposure to lithium, rare earths, and other essential battery materials. This matters because Australia hosts significant reserves and production capacity—companies like Lynas and Ivz stand to benefit from supply chain diversification away from China. Watch for earnings upgrades, capital raising announcements, and spodumene/rare earth pricing as these companies scale production to meet US demand.

The ASX 200 hit a record close driven by strength in mining and tech stocks, while financials took a breather after recent gains. Glencore's potential ASX listing is significant—if it proceeds, it would bring one of the world's largest commodity traders to the Australian exchange, boosting liquidity and deepening the country's resources market. Watch for confirmation of the listing timeline and any regulatory approvals, as this could attract institutional capital and reshape the ASX's commodity trading landscape.

Electronic Arts has been acquired by Saudi Arabia's Public Investment Fund and Affinity Partners (backed by Jared Kushner) for $55bn, marking one of gaming's largest deals. This is a significant M&A event but not a market-moving macro catalyst—it reflects investor appetite for entertainment IP rather than signalling economic shifts. Australian investors with EA exposure will see positions delisted from the ASX (though EA trades on NASDAQ), while the broader gaming sector may face consolidation scrutiny from regulators globally.

Lime has issued forward guidance projecting $1.04B–$1.1B in 2026 revenue with adjusted EBITDA of $265M–$285M, signalling confidence in profitability as the e-scooter company strengthens its balance sheet post-IPO. The outlook suggests the company is trending toward sustainable operations after years of heavy losses, though these are management targets rather than guaranteed results. Australian investors should note micromobility is an emerging but niche sector; the key takeaway is whether Lime can convert scale into real profitability—watch quarterly results and unit economics in coming quarters.

Europe's severe drought is creating a double squeeze: low water levels on major rivers like the Rhine and Danube are restricting barge transport for coal, grain, and industrial goods, while also limiting hydroelectric power generation when demand is highest. This threatens to push up energy prices and inflation across the continent at a time when the ECB is already wrestling with rate decisions. For Australian investors, this matters because European energy and commodity prices influence global markets—higher European energy costs could persist longer if drought worsens, supporting commodity prices but also signalling broader economic slowdown in a key trading partner.

The U.S. is reportedly pushing to announce a deal related to the Strait of Hormuz by Wednesday, though Iran is signalling potential delays. The Strait of Hormuz is critical infrastructure for global oil trade—roughly 20% of the world's crude passes through it—making any agreement on its security or navigation directly relevant to energy prices. While details are sparse, geopolitical de-escalation in the region would typically support lower oil prices and reduced market volatility; conversely, further delays could sustain uncertainty. Australian investors should monitor oil prices (ASX energy stocks like $WPL and $STO are sensitive to crude swings) and watch for formal announcements by Wednesday to assess whether this moves markets or fizzles.

China's services sector expansion has slowed to a 22-month low, signalling weakening domestic demand and economic momentum in the world's second-largest economy. The PBoC's stepped-up liquidity measures suggest policymakers are concerned about growth, likely indicating more rate cuts or stimulus ahead. For Australian investors, a softer Chinese economy pressures commodity prices and corporate earnings from companies with China exposure—though cheaper money in Beijing could eventually support demand recovery.